Atai Life Sciences (ATAI) News Today → Log Into Marc's $5,000 System Today (From Chaikin Analytics) (Ad) Free ATAI Stock Alerts $1.66 +0.05 (+3.11%) (As of 05/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 27 at 5:58 PM | seekingalpha.comATAI: Enormous Potential Upside But No Clarity YetMay 23, 2024 | finance.yahoo.comatai Life Sciences Strengthens Board with Appointment of Two New Independent DirectorsMay 23, 2024 | proactiveinvestors.comatai Life Sciences bolsters board with two new directorsMay 17, 2024 | markets.businessinsider.comBuy Recommendation for ATAI Life Sciences Amidst Cost-Optimization and Promising Clinical MilestonesMay 17, 2024 | markets.businessinsider.comBuy Rating Affirmed for ATAI Life Sciences Amid Promising TRD Treatment Developments and Strategic Growth PotentialMay 16, 2024 | proactiveinvestors.comatai Life Sciences poised to create value as psychedelic therapies gain traction, analysts believeMay 15, 2024 | proactiveinvestors.comatai Life Sciences boss makes way for co-founder on better first quarterMay 15, 2024 | globenewswire.comatai Life Sciences Reports First Quarter 2024 Financial Results and Corporate UpdatesMay 2, 2024 | forbes.comHow AI Could Transform Drug Development And The Life SciencesMay 1, 2024 | finance.yahoo.comOpioid Withdrawal Syndrome Drug Market to Surge at a CAGR of 4.0% by 2034 | DelveInsightApril 30, 2024 | forbes.comAI Is Moving Biology From Science To Engineering, Advancing MedicineApril 24, 2024 | proactiveinvestors.comatai Life Sciences investee Beckey Psytech starts dosing patients in second part of treatment-resistant depression studyApril 24, 2024 | finance.yahoo.comatai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant DepressionApril 24, 2024 | globenewswire.comatai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech's Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant DepressionApril 18, 2024 | stockhouse.comatai Life Sciences Announces the Publication of Beckley Psytech's Phase 1 Study of BPL-003 in the Journal of PsychopharmacologyApril 18, 2024 | investing.comatai Life Sciences reports positive Phase 1 results for BPL-003April 17, 2024 | finance.yahoo.comatai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of PsychopharmacologyApril 17, 2024 | proactiveinvestors.comatai announces publication of Beckley Psytech's Phase 1 study for novel 5-MeO-DMT assetApril 17, 2024 | msn.comAtai Life Sciences N.V. (ATAI) Price Target Decreased by 15.35% to 10.90April 15, 2024 | proactiveinvestors.comatai Life Sciences CEO Florian Brand spotlights psychedelic therapy milestones and upcoming catalystsApril 6, 2024 | investing.comAtai Life Sciences executive sells $114k in company stockApril 4, 2024 | msn.comAre You Looking for a Top Momentum Pick? Why atai Life Sciences N.V. (ATAI) is a Great ChoiceApril 3, 2024 | msn.comAtai Life Sciences upgraded at Maxim on Beckley investmentApril 2, 2024 | msn.comUT Tyler University Academy senior directs first student-led theater productionApril 1, 2024 | msn.comCould We Ever Have Sci-Fi Tech Like the ‘Star Trek’ Transporter? A New Roddenberry Entertainment Podcast Finds OutApril 1, 2024 | finance.yahoo.comAtai Life Sciences Full Year 2023 Earnings: EPS Beats Expectations, Revenues LagMarch 29, 2024 | msn.comAtai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic PipelineMarch 28, 2024 | msn.comIntranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant DepressionMarch 28, 2024 | benzinga.comRecap: ATAI Life Sciences Q4 EarningsMarch 28, 2024 | proactiveinvestors.comatai Life Sciences funded into 2026; sets sights on key milestones for its psychedelic therapiesMarch 28, 2024 | msn.comATAI Life Sciences GAAP EPS of -$0.12 beats by $0.04March 28, 2024 | globenewswire.comatai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical HighlightsMarch 27, 2024 | proactiveinvestors.comatai-backed Beckley Psytech unveils positive results from DMT for treatment-resistant depression studyMarch 27, 2024 | markets.businessinsider.comAtai Life: Beckley Psytech's Phase 2a Trial Of BPL-003 Positive In Treatment Resistant DepressionMarch 27, 2024 | finance.yahoo.comatai Life Sciences Announces Positive Initial Results from Beckley Psytech’s Phase 2a Open Label Study of BPL-003 (Intranasal 5-MeO-DMT) in Treatment Resistant DepressionMarch 27, 2024 | globenewswire.comatai Life Sciences Announces Positive Initial Results from Beckley Psytech's Phase 2a Open Label Study of BPL-003 (Intranasal 5-MeO-DMT) in Treatment Resistant DepressionMarch 15, 2024 | morningstar.comThinking about buying stock in Lexicon Pharmaceuticals, Cassava Sciences, Clearside Biomedical, Lantern Pharma, or ATAI Life Sciences?March 14, 2024 | finance.yahoo.comCaris Life Sciences to Showcase Research at 2024 SGO Annual Meeting on Women's CancerMarch 14, 2024 | msn.comPsychedelic drug ibogaine hailed as healing. U.S. patients ask why it’s illegal.March 12, 2024 | finance.yahoo.comatai Life Sciences advances VLS-01 for treatment-resistant depressionMarch 8, 2024 | finance.yahoo.comATAI Apr 2024 1.500 putMarch 8, 2024 | finance.yahoo.comATAI Apr 2024 2.000 callMarch 4, 2024 | proactiveinvestors.comatai Life Sciences doses first patient in Phase 1b study of its optimized oral DMT formulationMarch 4, 2024 | globenewswire.comatai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01February 28, 2024 | globenewswire.comatai Life Sciences to Participate in the Upcoming TD Cowen 44th Annual Health Care ConferenceFebruary 22, 2024 | benzinga.comATAI Life Sciences Stock (NASDAQ:ATAI), Quotes and News SummaryFebruary 17, 2024 | finance.yahoo.comATAI Mar 2024 2.000 callFebruary 15, 2024 | finance.yahoo.comATAI Feb 2024 1.500 putFebruary 15, 2024 | finance.yahoo.comATAI Mar 2024 1.500 putFebruary 15, 2024 | finance.yahoo.comATAI Aug 2024 1.500 call Get Atai Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATAI and its competitors with MarketBeat's FREE daily newsletter. Email Address Log Into Marc's $5,000 System Today (Ad)New Panic Could Sweep America Mark these words in 2024. Everyone's going to cash… Wall Street legend says: "A little-known vehicle outside of banks could double… triple… or even quadruple your life savings if you know where to find it right now." We urge you to move your cash into this vehicle in 2024. More here. ATAI Media Mentions By Week ATAI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATAI News Sentiment▼1.030.87▲Average Medical News Sentiment ATAI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATAI Articles This Week▼52▲ATAI Articles Average Week Get Atai Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATAI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PRTA News Today ARQT News Today SAVA News Today GYRE News Today INVA News Today BCYC News Today VRNA News Today LQDA News Today OPK News Today IRWD News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATAI) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersWARNING about the death of the U.S. dollar…Colonial MetalsDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsElon’s New Device is About to Shock the WorldInvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atai Life Sciences Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
